Paxman Q2’23: Strong growth and Positive Outlook - Redeye

Redeye sees continued strong sales progression driven by the right underlying factors. The better-than-expected sales and continued bright outlook confirm our positive stance on the potential for Paxman in the future. With some minor adjustments to our estimates due to the beat of our estimates and a slight increase in cost, we maintain our fair value range and range of SEK 39 to SEK 130 per share with a Base case value of SEK 86 per share.

Länk till analysen i sin helhet: https://www.redeye.se/research/938356/paxman-q223-riding-the-positive-market-momentum?utm_source=finwire&utm_medium=RSS